Background: In 1999, the National Representatives of European Society for Medical Oncology (ESMO) created a Palliative Care Working Group to improve the delivery of supportive and palliative care (S + PC) by oncologists, oncology departments and cancer centers. They have addressed this task through initiatives in policy, education, research and incentives. As an incentive program for oncology departments and centers, ESMO developed a program of Designated Centers (DCs) for programs meeting predetermined targets of service development and delivery of a high level of S + PC.
introduction
Over the past 30 years, there have been major developments in the standards of practice in palliative and supportive care for patients with advanced cancer [1] [2] [3] . Importantly, it is now widely acknowledged that a palliative and supportive care approach to care should utilized whenever needs are identified, irrespective of the stage of the disease, and not only at the end of life [2, [4] [5] [6] [7] [8] [9] . By implication, many patients receiving active disease-modifying treatment will need palliative and supportive care as part of a comprehensive care plan. For patients with advanced and refractory cancer, when the risks outweigh the benefits of anticancer treatments, palliative care becomes the most important paradigm of good cancer care [4, 5] .
Despite these developments, a parallel literature also indicated that many oncologists and cancer clinics have not integrated these evolving standards into training programs [10] [11] [12] [13] , routine practice [10, [14] [15] [16] [17] [18] [19] , research strategies [20, 21] or the resourcing of cancer departments and centers [10, 22] . The European Society for Medical Oncology (ESMO) recognizes that ensuring that patients with physical, psychological and social needs receive palliative and supportive care to address these issues is the responsibility of the medical oncology community. This does not imply that they must personally deliver all this care, but rather that they should ensure that these issues are being adequately addressed in cooperation with interdisciplinary professional team including home care services, nurses, social workers, physicians with expertise in palliative care, chaplains and mental healthcare professionals. Furthermore, ESMO recognizes that lack of uptake of standards in these aspects of cancer care is not only harming some patients and their families but also detrimental to the profession itself [9, 10] .
In 1999, the National Representatives of ESMO created a Palliative Care Working Group (PCWG) to address this issue. The charter of the working group is to improve the delivery of supportive and palliative care (S + PC) by oncologists, oncology departments and cancer centers. The PCWG and ESMO have addressed this task through initiatives in policy, education, research and incentives. In 2003, ESMO issued a policy document including definitions of S + PC, defining the responsibilities of the oncologist in the provision of palliative and supportive care, outlining training requirements for oncologists in relation to these aspect of patient care and establishing minimal standards for provision of palliative care in cancer centers [10] . These policies oblige individual members, associated organizations and affiliated centers to aspire to these standards. The ESMO policies regarding S + PC have been widely cited and, in some countries, ratified as national policy.
The education initiatives of the PCWG program have included elucidation of the core elements of Palliative Care Education for Oncology trainees [10] , the development of an ESMO Handbook of Advanced Cancer Care [23] , incorporation of palliative and supportive care into ESMO conferences and sponsored educational activities and two incentive programs to further promote this endeavor. The first, and most novel, was to develop an incentive program for oncology departments and cancer centers by offering special recognition for meeting predetermined targets of service development and delivery of a high level of S + PC. This program is known as the ESMO Program for Designated Centers (DCs) in the Integration of Oncology and Palliative Care. It is commonly referred to by an abbreviated name: the DC Program.
ESMO Program for DCs in the Integration of Oncology and Palliative Care conceptual development of the DC Program
In 1998, Catane and Cherny proposed the concept of an incentive program as part of the initial PCWG proposal that was presented to the National Representatives. The initial formulation had been to develop an accreditation program for centers of excellence for Integration of Oncology and Palliative Care, based on the model of the Comprehensive Cancer Center (CCC) designation by the National Cancer Institute [24, 25] .
After the formation of the PCWG and at the request of the National Representatives, the concept of accrediting center of excellence was modified for two reasons; first, the identification and recognition of Centers of Excellence was considered too restrictive to be relevant to most oncology services or cancer centers, and secondly, it required a rigorous accreditation program in order to be credible. The concept was therefore modified to accredit centers which meet a challenging threshold for advanced program development. This threshold was considered to be medically substantial, readily achievable with due application and consistent with recognized international standards. This approach aimed for a threshold of service development that cancer centers could reasonably aim to attain even if they were starting from a low baseline of services, thus providing incentive to a wider range of institutions, not only those aiming for the pinnacle of excellence. This process was named the ESMO Program for DCs in the Integration of Oncology and Palliative Care.
development of the 13 criteria for accreditation
The criteria for accreditation were drafted based on recommendation from the World Health Organization guidelines on the provision of palliative care for patients with cancer [26] . An original list of 22 items was presented to a full meeting of the members of the PCWG and this was reduced to 13 core requirements by a process of consensus. The 13 criteria were ratified by the National Representatives in 2003 as face valid, fair, appropriate, reasonably comprehensive and adequately, but not excessively, challenging (Table 1) .
application and accreditation
Description of the DC Program, the accreditation criteria and the application process were published on the ESMO Web site and in ESMO newsletters. Starting in 2004, application was invited from all cancer centers and oncology departments meeting the criteria.
The application, made by the head of the department or cancer center, is submitted to the ESMO education department. The application consists of two parts. The first is a checklist indicating compliance with each of the 13 criteria. The second part requires a narrative description as to how the center meets each of the 13 criteria. Compliance with each criterion is described on a separate page signed, for veracity, by the head of the department and head of institute. Completed applications are blinded by the education office and distributed to three reviewers drawn from the PCWG. Accreditation is made on the basis of meeting all 13 criteria as determined by a review committee drawn up from the membership of the PCWG. If two to three of three reviewers agree that a criterion is not adequately met, this decision holds. If one of three reviewers assess a criterion as not adequately met, then this is reviewed by the accreditation chairperson for final adjudication. If five or less criteria are deemed to be inadequately met, the applicant is given the opportunity to elaborate further regarding the specific concerns. If the feedback is deemed adequate to the chair, then this is returned to the committee for reevaluation. If six or more criteria are deemed to be inadequately met, the application is deemed unsuccessful. Unsuccessful applicants receive feedback on the specific shortcomings and are encouraged to use this constructively in their service development and to reapply.
Accreditation is valid for 3 years and full reapplication is necessary for renewal. Certificates of accreditation are presented at the awards session of the ESMO or European Cancer Organization/ESMO congresses. Most of the 27 unsuccessful applications failed to meet 6-8 of the criteria listed in Table 1 . The most common unmet criteria were items 2 (continuity of care), 5 (patients assessment and timely response), 6 (staff credentials), 9 (inpatient symptom stabilization), 10 (respite care), 12 (research) and 13 (education).
characteristics of the accredited centers
Thirty-four of the DCs are CCCs in general hospitals, 24 of which are university affiliated. Seven of the centers are freestanding CCCs (Table 3) . Among these, are major centers such as Institut Jules Bordet in Belgium, Institut de Cancerologie Gustave Roussy in France, Institut Catala d'Oncologia in Spain and Charite University Hospital in Germany. Others are medical oncology departments in general (2) or university hospitals (1) and one is an oncology department in a dermatology hospital.
impact of ESMO accreditation on the DCs
In early 2008, the program directors of the 27 cancer centers that were accredited before that time were surveyed to evaluate the impact of the application process and the accreditation. Twenty-four responses were received. Four of the 24 centers had developed new services specifically to make themselves compliant with the 13 criteria. The perceived benefits accrued from the accreditation included improved status and role 
ESMO grantee visits to DCs
The second of the incentive programs of ESMO and the PCWG are the palliative care grants, awarded since 2006. These are special grants, of up to 5000 Euro, for oncologists or oncology fellows seeking additional experience in palliative care by spending 1-3 months of observation and/or research at one of the DCs. Candidates must be oncologists and ESMO members (or in process of application). The candidates must demonstrate approval of the project by their institutional 
revision of the accreditation criteria
The DC Program has continually been under review by both the PCWG and the national representatives. Both groups expressed concern regarding difficulty in describing how centers meet each of the 13 criteria for accreditation. In 2007, the PCWG began a process to review the accreditation criteria and the manner in which submissions are made. Suggestions for amendments were solicited from the members of the PCWG in early 2008. They were edited, drafted and presented for critical discussion at the meeting of all the designed centers in June 2008. The criteria have been amended (Table 5) to better reflect the issues of integration (items 1 and 2), credentialing (items 3 and 4), service provision (items 5-11), research (item 12) and education (item 13). Furthermore, guidelines for describing each of the criteria are presented to help structure the applications and facilitate evaluation. These new criteria will apply from 2009. [27] . The DC project is one of the more prominent elements of the ESMO initiative. In the world of oncology, it has sought to set a new standard for service development and delivery of integrated oncology and palliative care; a standard that is high enough to be worthy of special recognition, but not so high as to be beyond the reach of most centers.
There are several characteristics of the DC Program that deserve emphasis:
1 Creating incentives: The DC initiative aims to improve the relative advantage of adopting high-quality palliative care by giving it status. In doing so, ESMO is trying to influence the culture of oncology to emphasize the commonality of purpose and goals between good cancer care and good supportive care and that they are an irreducible unity. 2 Education with structure: Through the DC Program, ESMO has tried to reduce perceived complexity of developing integrated palliative care services by providing concrete guidelines and achievable targets and through the identification of hospitals and services that can serve as models and mentors for the development of new programs. 3 Importance irrespective of scope: The recognition awarded is not dependent in the size of the institute or the number of patients treated. Both large cancer centers and relatively The DC Program has not been without its critics. Issues of concern have included perceived difficulty in describing how centers meet each of the accreditation criteria, the underrepresentation of major centers among those that have achieved accreditation and the validity of the accreditation process. The PCWG have attempted to address each of these concerns.
The PCWG acknowledged the difficulties in addressing the narrative requirement of the application process and have revised the accreditation process accordingly. The revised criteria are clearer and the application process more structured with the incorporation of directive subpoints to be addressed in the application narratives. Well-recognized major cancer centers have less marginal benefit in prestige accrued from accreditation as a DC in the Integration of Oncology and Palliative Care and this may be one of the reasons for the predominance of smaller centers to date. This situation appears to change, and the 2008 cohort of successful candidacies included Institute Jules Bordet in Belgium and Institute de Cancerologie Gustave Roussy in France. We believe that the participation of major centers is important; it enhances the role modeling effect of the initiative and emphasizes their leadership in clinical and service development. We anticipate the participation of other major centers in 2009. Although there have been few successful applications from centers in the Former Soviet Union or from developing countries, those that have been successful are particularly notable. The PCWG have received many expressions of interest from centers in these regions and we are aware of programs using the criteria as a model for ongoing program development.
The PCWG and the ESMO Executives considered the introduction of validation site visits. After weighing the matter, the ESMO Executives felt the organization should not undertake auditing responsibility. Given that the aim of the project was to reward threshold achievements rather than excellence, it was agreed that the current system of blinded evaluation of applications by multiple independent reviewers is sufficiently valid for this purpose. This process relies on the integrity of the program directors and medical directors who attest, by their signature, to the accuracy of the submitted description of each of the required criteria in the application process.
In 2008, the PCWG undertook a series of site visits to document the work being done at the DCs and to study the ways in which centers had developed successful integrative programs. Visits were undertaken by members of the PCWG and representatives of the ESMO education office. Centers were asked to deliver a verbal presentation of the care facility, the department structure including a description of the healthcare team members and the activities which fulfill the current ESMO requirements for accreditation in integrated oncology and palliative care. This was followed by a guided visit of the facilities, highlighting how the facility functions and meets the ESMO criteria and an interdisciplinary team discussion. The information gleaned from these visits supported the validity of the accreditation process. The centers all lived up to the expectations generated by their submissions for candidacy. These visits rendered useful information for purposes of modeling different ways to integrate oncology and palliative care services. Furthermore, the centers were offered constructive suggestions for program development in a formal report by the visiting representatives and this feedback was appreciated. Reports on these visits are available through the ESMO Web site.
Addressing these intrinsic factors, the ESMO's initiative aims to improve the relative advantage of adopting high-quality palliative care by giving it a status and creating incentives. ESMO is trying to influence the culture of oncology to emphasize the commonality of purpose and goals between good cancer care and good supportive care and by emphasizing that they are an irreducible unity. Through its DC Program, ESMO has tried to reduce perceived complexity of developing integrated palliative care services by providing concrete guidelines and achievable targets and through the identification of hospitals and services that can serve as models and mentors for the development of new programs.
Conclusions
The accreditation of DCs in the Integration of Oncology and Palliative Care has been a key element in the ESMO initiative to improve the palliative care provided by oncologists and oncology centers. The DC initiative emphasized the priority of this endeavor. The 48 centers that have achieved accreditation serve as a valuable nucleus for education and role modeling. The modifications made to the program will improve the application and evaluation processes. It is likely that many other oncology departments and cancer centers already meet the criteria, and ESMO strongly encourages them to apply for accreditation. Furthermore, to improve quality of cancer care, ESMO urges oncology units and cancer centers which do not yet meet these standards, to develop programs in order to meet these pragmatic and clinically significant benchmarks and thus further improve cancer care in Europe and beyond.
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